Advertisement
UK markets closed
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • HANG SENG

    16,541.42
    +148.58 (+0.91%)
     
  • CRUDE OIL

    83.12
    +1.77 (+2.18%)
     
  • GOLD FUTURES

    2,239.20
    +26.50 (+1.20%)
     
  • DOW

    39,781.14
    +21.06 (+0.05%)
     
  • Bitcoin GBP

    55,849.12
    +1,390.44 (+2.55%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • NASDAQ Composite

    16,380.73
    -18.79 (-0.11%)
     
  • UK FTSE All Share

    4,338.05
    +12.12 (+0.28%)
     

Bear of the Day: Fresenius Medical (FMS)

The latest move higher in the market has boosted up all kinds of stocks. That means, even stocks with weak earnings trend have rebounded because they were simply so oversold. Be careful when you come in and buy the dip blindly. Sometimes, the stocks that are going up along with the rest of the market are not the quality names that you should be betting on.

One way to avoid stocks with weak earnings trends is passing on Zacks Rank #5 (Strong Sell) stocks. These stocks have seen earnings estimates drop over the last few weeks, which means that Wall Street could be turning bearish. Today’s Bear of the Day is one such stock. I’m talking about Zacks Rank #5 (Strong Sell) Fresenius Medical FMS.

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. 

Zacks Investment Research
Zacks Investment Research


Image Source: Zacks Investment Research

ADVERTISEMENT

The reason for the unfavorable rank is that over the last 60 days, three analysts have cut estimates for the current year and next year. The negative moves have cut our Zacks Consensus Estimate for the current year from $1.67 to $1.46 while next year’s number is off from $1.86 to $1.56. That’s a 29% contraction this year and growth of just 6.7% next year.

The Medical -Instruments Peers industry ranks in the Bottom 48% of our Zacks Industry Rank. Investors looking for other names in this industry can check out Zacks Rank #1 (Strong Buy) Mesa Laboratories MLAB and Zacks Rank #2 (Buy) Accuray ARAY.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Accuray Incorporated (ARAY) : Free Stock Analysis Report
 
Fresenius Medical Care AG & Co. KGaA (FMS) : Free Stock Analysis Report
 
Mesa Laboratories, Inc. (MLAB) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research